These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 462128)

  • 1. Cefamandole nafate: an evaluation of antibacterial activity, serum levels, clinical effect, and incidence of side reactions in 58 patients.
    Ekwall E; Holmgren EB; Lundbergh P; Svanbom M; Tunevall G
    Scand J Infect Dis; 1979; 11(2):135-9. PubMed ID: 462128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of cefamandole nafate.
    Rosett W; Hodges GR; Harms J; Gerjarusak P; Dworzack D; Hinthorn DR; Liu C
    Am J Med Sci; 1977; 274(2):153-61. PubMed ID: 341707
    [No Abstract]   [Full Text] [Related]  

  • 3. Cefamandole in the treatment of soft tissue infections.
    Ramírez-Ronda CH; Quiñones-Soto R; Lugo-Velázquez A; Bermúdez RH
    Chemotherapy; 1982; 28(3):224-8. PubMed ID: 7094663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefamandole nafate therapy of respiratory tract, skin, and soft tissue infections in 74 patients.
    Perkins RL; Fass RJ; Warner JF; Prior RB; File TM; Tight RR; Gardner WG; Ruiz DE; Slama TG
    J Infect Dis; 1978 May; 137 Suppl():S110-S118. PubMed ID: 418126
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of cefamandole plus either gentamicin or tobramycin in therapy of severe gram-negative bacterial infections.
    Gentry LO
    J Infect Dis; 1978 May; 137 Suppl():S144-S149. PubMed ID: 349093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and laboratory investigation of cefamandole therapy of infections in infants and children.
    Azimi PH
    J Infect Dis; 1978 May; 137 Suppl():S155-S160. PubMed ID: 349094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of cefamandole in the treatment of soft tissue and skeletal infections.
    LeFrock JL; Paparone P; Kowalsky SF; Schell RF; Jacobs RL; Wirth CR; Tillotson JR
    Drug Intell Clin Pharm; 1981 Dec; 15(12):951-7. PubMed ID: 7338190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and laboratory investigation of cefamandole in infections of infants and children.
    Azimi PA
    Antimicrob Agents Chemother; 1978 Jun; 13(6):955-7. PubMed ID: 307939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, controlled trial of cefoperazone vs. cefamandole-tobramycin in the treatment of putative, severe infections with gram-negative bacilli.
    Warren JW; Miller EH; Fitzpatrick B; DiFranco DE; Caplan ES; Tenney JH; Anthony WC
    Rev Infect Dis; 1983; 5 Suppl 1():S173-80. PubMed ID: 6221388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefamandole nafate therapy in the treatment of acute urinary tract infections.
    Short HD; Gentry LO; Sessoms S
    J Antimicrob Chemother; 1976 Dec; 2(4):345-50. PubMed ID: 802125
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacokinetics and clinical studies of a new cephalosporin: cefamandole nafate].
    Di Nola F; Eandi M; Capra E; Soranzo ML; Bosio G; Bramato C; Salassa B; Andrini L; Robecchi GA
    Minerva Med; 1980 May; 71(21):1515-24. PubMed ID: 7383410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefamandole in treatment of peritonitis.
    Stone HH; Guest BS; Geheber CE; Kolb LD
    J Infect Dis; 1978 May; 137 Suppl():S103-S109. PubMed ID: 649995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical versus systemic cephalosporin administration in elective biliary operations.
    Freischlag J; McGrattan M; Busuttil RW
    Surgery; 1984 Oct; 96(4):686-93. PubMed ID: 6435272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pediatric experiences with cefamandole nafate].
    Perinotto G; Belloni CL; Robecchi GA; Fiorella G
    Clin Ter; 1981 Apr; 97(2):165-74. PubMed ID: 7237956
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical experience with cefamandole for treatment of serious bone and joint infections.
    Levine LR; McCain E
    J Infect Dis; 1978 May; 137 Suppl():S119-S124. PubMed ID: 649996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of cefamandole on urinary tract and genital organ infections (author's transl)].
    Doi S; Fujimoto A; Ito M; Sugimoto O; Tsujii K
    Jpn J Antibiot; 1980 Apr; 33(4):411-5. PubMed ID: 6997528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delineation of the relative antibacterial activity of cefamandole and cefamandole nafate.
    Turner JR; Preston DA; Wold JS
    Antimicrob Agents Chemother; 1977 Jul; 12(1):67-72. PubMed ID: 18988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefamandole in the treatment of infections due to Enterobacter and indole-positive Proteus.
    Levine LR; McCain E
    J Infect Dis; 1978 May; 137 Suppl():S125-S132. PubMed ID: 649997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy of serious infections with cefamandole.
    Parry MF; Goldberger MJ; Neu HC
    Infection; 1978; 6(5):236-40. PubMed ID: 365776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fundamental and clinical studies on cefamandole in pediatric treatment (author's transl)].
    Motohiro T; Sakata Y; Nishiyama T; Nakajima T; Imai H; Ishimoto K; Tominaga K; Yamashita F; Takeya S
    Jpn J Antibiot; 1979 Sep; 32(9):930-7. PubMed ID: 501920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.